Our study reveals a novel interaction between Th17.1 cells and M2-like macrophages in Type III granulomas potentially mediated through CD47-SIRPα, which may contribute to impaired antigen processing and glucocorticoid resistance in sarcoidosis. Therapies targeting this molecular pathway represent a promising direction for developing new sarcoidosis treatments.
No takes yet. Share an insight, caveat, or question.
Zhao et al. (2025) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: